These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3689627

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.
    MacFadyen RJ, Lees KR, Reid JL.
    Br J Clin Pharmacol; 1994 Oct; 38(4):329-34. PubMed ID: 7833222
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril.
    Jakobsen J, Glaus L, Graf P, Degen P, Maurice NP, Bellet M, Ménard J.
    J Hypertens; 1992 Sep; 10(9):1045-51. PubMed ID: 1328364
    [Abstract] [Full Text] [Related]

  • 25. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC, Ames MK, Werre S, Atkins CE.
    J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
    [Abstract] [Full Text] [Related]

  • 26. CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers.
    Jacot des Combes B, Turini GA, Brunner HR, Porchet M, Chen DS, Sen S.
    J Cardiovasc Pharmacol; 1983 Oct; 5(4):511-6. PubMed ID: 6193344
    [Abstract] [Full Text] [Related]

  • 27. Haemodynamic (systemic and renal) and humoral interactions between nicardipine and domperidone in hypertensives.
    Lucarini AR, Salvetti A.
    J Hypertens Suppl; 1987 Dec; 5(5):S571-4. PubMed ID: 3327930
    [Abstract] [Full Text] [Related]

  • 28. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.
    Manhem PJ, Ball SG, Morton JJ, Murray GD, Leckie BJ, Fraser R, Robertson JI.
    Br J Clin Pharmacol; 1985 Jul; 20(1):27-35. PubMed ID: 2992562
    [Abstract] [Full Text] [Related]

  • 29. Experience with perindopril in normal volunteers.
    Waeber B, Nussberger J, Perret L, Santoni JP, Brunner HR.
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [Abstract] [Full Text] [Related]

  • 30. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
    Chodjania Y, Tharaux PL, Ragueneau I, Dussaule JC, Picker JL, Funck-Brentano C, Jaillon P.
    Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
    [Abstract] [Full Text] [Related]

  • 31. Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers.
    Bidiville J, Porchet M, Bussien JP, Nussberger J, Waeber B, Brunner HR.
    Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):109-19. PubMed ID: 2959228
    [Abstract] [Full Text] [Related]

  • 32. Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
    Rousso P, Buclin T, Nussberger J, Brunner-Ferber F, Brunner HR, Biollaz J.
    Eur J Clin Pharmacol; 2000 Jan; 55(10):749-54. PubMed ID: 10663454
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Experience with perindopril in normal volunteers.
    Waeber B, Nussberger J, Perret L, Santoni JP, Brunner HR.
    Clin Exp Hypertens A; 1989 Jan; 11 Suppl 2():507-19. PubMed ID: 2605800
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of angiotensin-converting enzyme with libenzapril in normotensive males.
    Morgan JM, Piraino AJ, Saris SD, Graham CS, Hirschhorn WL, Kochak GM, Choi RL.
    J Clin Pharmacol; 1994 Dec; 34(12):1177-82. PubMed ID: 7738213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.